Michael Byrnes
Board Member
Cero Therapeutics Holdings, Inc. (CERO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Byrnes
Michael Byrnes is recorded as Board Member at Cero Therapeutics Holdings, Inc. (CERO). Cero Therapeutics Holdings, Inc. reported in an 8-K filed May 29, 2025 that Michael Byrnes was appointed Class I director, effective May 29, 2025. Cero Therapeutics Holdings, Inc. reported in an 8-K filed February 15, 2024 that Michael Byrnes was appointed director of the Company.
“To approve the election of two Class I directors to the Board, to serve until the 2028 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal.”
“Mr. Byrnes, Mr. Atwood, Ms. LaPorte, Mr. Corey and Mr. Ehrlich were appointed as directors of the Company, to serve until the end of their respective terms and until their successors are elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cero Therapeutics Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian G. Atwood CEO, Chairman
- Chris Ehrlich CEO, Chairman, Board Member
- Andrew Albert "Al" Kucharchuk CFO
- Andrew Albert Kucharchuk CFO
- Andrew Albert “Al” Kucharchuk CFO
- Charles Carter CFO
- Daniel Corey CTO, Board Member
- Eric Francois Board Member
- Lindsey Rolfe Board Member
- Lindsey Rolfe, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.